Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • News
  • Industry
  • Pharma News
  • 37 Essential Drugs...

37 Essential Drugs Including Paracetamol, Atorvastatin To Get Cheaper, NPPA Issues Revised Price List

Farhat NasimWritten by Farhat Nasim Published On 2025-08-04T15:00:10+05:30  |  Updated On 5 Aug 2025 2:31 AM IST
37 Essential Drugs Including Paracetamol, Atorvastatin To Get Cheaper, NPPA Issues Revised Price List
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

New Delhi: Through a recent Gazette notification, the National Pharmaceutical Pricing Authority (NPPA), under the Ministry of Chemicals and Fertilizers, has fixed the retail prices of 37 widely used essential drug formulations, including those used to treat infections, heart diseases, inflammatory conditions, diabetes, and vitamin deficiencies.

Notable among the revised formulations is a triple-combination anti-inflammatory tablet containing Aceclofenac, Paracetamol, and Trypsin Chymotrypsin. The NPPA has capped its retail price at Rs 13 per tablet when marketed by Dr. Reddy’s Laboratories and Rs 15.01 when marketed by Cadila Pharmaceuticals. Another major change affects the cardiovascular segment: a bilayer tablet combining Atorvastatin 40 mg and Clopidogrel 75 mg is now priced at Rs 25.61 per unit.

The revised list also includes several pediatric oral suspensions—such as those based on Cefixime and Paracetamol—as well as key nutritional and injectable therapies. For instance, Cholecalciferol (Vitamin D) drops and Diclofenac injection have been priced at Rs 6.11 per ml and Rs 31.77 per ml, respectively.

In the anti-diabetic segment, critical combinations such as Empagliflozin, Sitagliptin, and Metformin Hydrochloride—used extensively in type 2 diabetes management—are now capped at Rs 16.50 per tablet. Fixed-dose cholesterol medications like Atorvastatin-Ezetimibe and respiratory therapies including Bilastine-Montelukast for allergic rhinitis and asthma also feature among the newly priced formulations.

In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S.O. 5249(E) dated 11th November, 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the Authority has fixed, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;

Table

Sl.

No.

Medicines

Strength

Unit

Manufacturer & Marketing Company

Retail

Price

(Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

1

Aceclofenac,

Paracetamol &

Trypsin

Chymotrypsin

Tablets

Each enteric coated tablet contains: Proteolytic enzymes Trypsin & Chymotrypsin in the ratio of Approximately 6:1 and provides enzymatic activity Eq. to

1,50,000 Armour units

Aceclofenac IP 100 mg

1 Tablet

M/s Akums Drugs &

Pharmaceuticals Ltd./

M/s Dr. Reddy’s Laboratories Ltd.

13.00

Sl.

No.

Medicines

Strength

Unit

Manufacturer & Marketing Company

Retail

Price

(Rs.)

Paracetamol IP 325 mg

2

Aceclofenac,

Paracetamol &

Trypsin

Chymotrypsin

Tablets

Each enteric coated tablet contains: Proteolytic enzymes Trypsin & Chymotrypsin in the ratio of Approximately 6:1 and provides enzymatic activity Eq. to

1,50,000 Armour units

Aceclofenac IP 100 mg

Paracetamol IP 325 mg

1 Tablet

M/s Akums Drugs &

Pharmaceuticals Ltd./ M/s Cadila Pharmaceuticals Ltd.

15.01

3

Amoxycillin &

Potassium Clavulanate Oral suspension

Each 5 ml of reconstituted suspension contains: Amoxycillin Trihydrate IP equivalent to Amoxycillin 600 mg Potassium Clavulanate Diluted IP

equivalent to Clavulanic Acid 42.9 mg

1 ml

M/s Copmed Pharmaceuticals

Pvt. Ltd./

M/s Zydus Healthcare Ltd.

3.32

4

Atorvastatin &

Clopidogrel Tablets

Each uncoated bilayered tablet contains:

Atorvastatin Calcium IP

Equivalent to Atorvastatin 40 mg Clopidogrel Bisulphate IP equivalent to Clopidogrel 75 mg

1 Tablet

M/s Pure and Cure Healthcare Pvt. Ltd./

M/s Lupin Ltd.

25.61

5

Atorvastatin &

Ezetimibe Tablets

Each Film Coated Tablet

Contains: Atorvastatin Calcium IP

Eq. to Atorvastatin 10 mg

Ezetimibe IP 10 mg

1 Tablet

M/s Pure and Cure Healthcare

Pvt. Ltd./

M/s Cadila Pharmaceuticals Ltd.

19.86

6

Atorvastatin &

Ezetimibe Tablets

Each Film Coated Tablet

Contains: Atorvastatin Calcium IP

Eq. to Atorvastatin 20 mg

Ezetimibe IP 10 mg

1 Tablet

M/s Pure and Cure Healthcare

Pvt. Ltd./

M/s Cadila Pharmaceuticals Ltd.

30.10

7

Atorvastatin &

Ezetimibe Tablets

Each Film Coated Tablet

Contains: Atorvastatin Calcium IP

Eq. to Atorvastatin 40 mg

Ezetimibe IP 10 mg

1 Tablet

M/s Pure and Cure Healthcare

Pvt. Ltd./

M/s Cadila Pharmaceuticals Ltd.

30.47

8

Atorvastatin Calcium and Clopidogrel

Capsules

Each hard gelatin capsule contains: Atorvastatin Calcium IP equivalent to Atorvastatin 10mg

(As pellets) Clopidogrel

Bisulphate IP equivalent to

Clopidogrel 75mg (As pellets)

1 Capsule

M/s Synokem

Pharmaceuticals Ltd./

M/s Alkem Laboratories Ltd.

15.94

9

Atorvastatin,

Clopidogrel and

Aspirin Capsules

Each hard gelatin capsule contains: Atorvastatin Calcium IP

Eqv. to Atorvastatin 10 mg (As

Pellets)

Clopidogrel Bisulphate İP

Eq. to Clopidogrel 75 mg (As

Pellets)

Aspirin IP 75 mg

(As enteric coated Pellets)

1 Capsule

M/s Synokem

Pharmaceuticals Ltd./ M/s Aristo Laboratories Pvt.

Ltd.

5.88

10

Atorvastatin,

Clopidogrel and

Aspirin Capsules

Each hard gelatin capsule contains: Atorvastatin Calcium IP

Eqv. to Atorvastatin 20 mg (As

Pellets)

Clopidogrel Bisulphate IP

1 Capsule

M/s Synokem

Pharmaceuticals Ltd./ M/s Aristo Laboratories Pvt.

Ltd.

8.33

Sl.

No.

Medicines

Strength

Unit

Manufacturer & Marketing Company

Retail

Price

(Rs.)

Eq. to Clopidogrel 75 mg (As

Pellets)

Aspirin IP 75 mg

(As enteric coated Pellets)

11

Bilastine &

Montelukast Tablet

Each film coated bilayered tablet contains:

Bilastine IP 40 mg

Montelukast Sodium IP eq. to

Montelukast 10 mg

1 Tablet

M/s Akums Drugs & Pharmaceuticals Ltd./ M/s Lupin Ltd.

22.78

12

Bisoprolol Fumarate

& Amlodipine

Tablets

Each film coated tablet contains:

Bisoprolol Fumarate IP 2.5 mg Amlodipine Besylate IP equivalent to Amlodipine 5 mg

1 Tablet

M/s Swiss Garnier Life

Sciences/

M/s Cadila Pharmaceuticals Ltd.

6.70

13

Cefixime Oral

Suspension

(Combipack)

One Combipack contains:

Part (A) Each 5ml of reconstituted suspension contains: Cefixime IP equivalent to

Cefixime Anhydrous 200 mg

Part (B) Each ampoule contains

Sterile Water for Injection IP 25ml

1 ml

M/s Alps Communication Pvt.

Ltd./

M/s Aristo Pharmaceuticals Pvt. Ltd.

3.72

14

Cefixime,

Dicloxacillin (CR) and Lactic Acid Bacillus Tablets

Each film coated tablet contains:

Cefixime IP as Trihydrate Eq. to

Anhydrous Cefixime 200mg

Dicloxacillin Sodium IP Eq. to Dicloxacillin 500 mg (Controlled release)

Lactic Acid Bacillus 2.5 Billion

Spores (Appropriate Overages of

Lactic Acid Bacillus Spores

Added)

1 Tablet

M/s Akums Drugs &

Pharmaceuticals Ltd. /

M/s Alkem Laboratories Ltd.

15.25

15

Cholecalciferol Oral Drops

Each ml contains:

Cholecalciferol (Vitamin D3) IP

800 IU (as Stabilized)

1 ml

M/s Ravenbhel Biotech/

M/s Zydus Healthcare Ltd.

6.11

16

Cilnidipine &

Telmisartan Tablets

Each film coated tablet contains:

Cilnidipine IP 20 mg

Telmisartan IP 40 mg

1 Tablet

M/s Akums Drugs & Pharmaceuticals Ltd./ M/s Lupin Ltd.

14.51

17

Diclofenac Sodium,

Paracetamol &

Chlorzoxazone

Tablets

Each uncoated tablet contains:

Diclofenac Sodium IP 50 mg

Paracetamol IP 325 mg

Chlorzoxazone USP 250 mg

1 Tablet

M/s Innova Captab Ltd./ M/s Dr. Reddys Laboratories Ltd.

6.03

18

Escitalopram Oxalate

& Clonazepam

Tablets

Each Film Coated Tablet Contains:

Escitalopram Oxalate IP eq.to

Escitalopram 5 mg

Clonazepam IP 0.25 mg

1 Tablet

M/s Pure and Cure Healthcare Pvt. Ltd./

M/s Abbott Healthcare Pvt.

Ltd.

8.38

19

Paracetamol,

Phenylephrine

Hydrochloride &

Chlorpheniramine

Maleate Tablets

Each uncoated tablet contains:

Paracetamol IP 500 mg

Phenylephrine Hydrochloride IP

10 mg

Chlorpheniramine Maleate IP 2 mg

1 Tablet

M/s East African (I) Overseas / M/s Troikaa Pharmaceuticals Ltd.

5.15

20

Empagliflozin, Linagliptin &

Each film coated bilayer tablet contains:

1 Tablet

M/s Exemed Pharmaceuticals / M/s Corona Remedies Pvt.

33.13

Sl.

No.

Medicines

Strength

Unit

Manufacturer & Marketing Company

Retail

Price

(Rs.)

Metformin

Hydrochloride

(Extended Release)

Tablets

Empagliflozin 25 mg

Linagliptin 5 mg

Metformin Hydrochloride IP 1000 mg (as extended release)

Ltd.

21

Empagliflozin,

Sitagliptin &

Metformin

Hydrochloride

(Extended Release)

Tablets

Each film coated bilayer tablet contains:

Empagliflozin 25 mg

Sitagliptin Phosphate

Monohydrate IP equivalent to

Sitagliptin 100 mg

Metformin Hydrochloride IP 1000 mg (as extended release)

1 Tablet

M/s Exemed Pharmaceuticals / M/s USV Ltd.

27.50

22

Empagliflozin,

Sitagliptin &

Metformin

Hydrochloride

(Extended Release)

Tablets

Each film coated bilayer tablet contains:

Empagliflozin 25 mg

Sitagliptin Phosphate

Monohydrate IP equivalent to

Sitagliptin 100 mg

Metformin Hydrochloride IP 1000 mg (as extended release)

1 Tablet

M/s Exemed Pharmaceuticals / M/s Micro Labs Ltd.

16.50

23

Empagliflozin,

Sitagliptin &

Metformin

Hydrochloride

(Extended Release)

Tablets

Each film coated bilayer tablet contains:

Empagliflozin 25 mg

Sitagliptin Phosphate

Monohydrate IP equivalent to

Sitagliptin 100 mg

Metformin Hydrochloride IP 1000 mg (as extended release)

1 Tablet

M/s Exemed Pharmaceuticals/ M/s Aristo Pharmaceuticals Pvt. Ltd.

17.42

24

Empagliflozin,

Sitagliptin &

Metformin

Hydrochloride

(Extended Release)

Tablets

Each film coated bilayer tablet contains:

Empagliflozin 10 mg

Sitagliptin Phosphate

Monohydrate IP equivalent to

Sitagliptin 100 mg

Metformin Hydrochloride IP 1000 mg (as extended release)

1 Tablet

M/s Exemed Pharmaceuticals/ M/s Aristo Pharmaceuticals Pvt. Ltd.

14.74

25

Empagliflozin &

Metformin

Hydrochloride

Tablets

Each film coated tablet contains:

Empagliflozin 12.5 mg

Metformin Hydrochloride IP 500 mg

1 Tablet

M/s Pure and Cure Healthcare

Pvt. Ltd./

M/s Eris Lifesciences Ltd.

18.70

26

Empagliflozin &

Metformin

Hydrochloride

Tablets

Each film coated tablet contains: Empagliflozin 12.5 mg

Metformin Hydrochloride IP 500 mg

1 Tablet

M/s Windlas Biotech Ltd./ M/s Medley Pharmaceuticals Ltd.

13.40

27

Empagliflozin &

Metformin

Hydrochloride

Tablets

Each film coated tablet contains: Empagliflozin 12.5 mg

Metformin Hydrochloride IP 1000 mg

1 Tablet

M/s Windlas Biotech Ltd./ M/s Medley Pharmaceuticals Ltd.

14.30

28

Sitagliptin +

Pioglitazone + Metformin

Hydrochloride

(Sustained Release)

Tablets

Each film coated bilayered tablet contains:

Sitagliptin Phosphate

Monohydrate IP eq. to Sitagliptin 100mg

Pioglitazone Hydrochloride IP eq.

1 Tablet

M/s Akums Drugs &

Pharmaceuticals Ltd./ M/s Workcell Solutions Pvt.

Ltd.

14.11

Sl.

No.

Medicines

Strength

Unit

Manufacturer & Marketing Company

Retail

Price

(Rs.)

to Pioglitazone 15mg

Metformin Hydrochloride IP (as sustained release form) 500mg

29

Sitagliptin,

Glimepiride & Metformin

Hydrochloride

Tablets

Each film coated bilayered tablet contains:

Sitagliptin Phosphate

Monohydrate IP 64.25 mg equivalent to Sitagliptin 50 mg

Glimepiride IP 1 mg

Metformin Hydrochloride IP 1000 mg

1 Tablet

M/s Tristar Formulations Pvt.

Ltd/

M/s Franco Indian

Pharmaceuticals Pvt. Ltd.

11.16

30

Sitagliptin,

Glimepiride & Metformin

Hydrochloride

Tablets

Each film coated bilayered tablet contains:

Sitagliptin Phosphate

Monohydrate IP 64.25 mg equivalent to Sitagliptin 50 mg

Glimepiride IP 2 mg

Metformin Hydrochloride IP 1000 mg

1 Tablet

M/s Tristar Formulations Pvt.

Ltd/

M/s Franco Indian

Pharmaceuticals Pvt. Ltd.

12.59

31

Sitagliptin,

Glimepiride & Metformin

Hydrochloride

Tablets

Each film coated tablet contains:

Sitagliptin Phosphate

Monohydrate IP equivalent to

Sitagliptin 50mg

Glimepiride IP 1 mg

Metformin Hydrochloride IP

500mg

1 Tablet

M/s Exemed Pharmaceuticals/ M/s Primus Remedies Pvt.

Ltd.

12.19

32

Sitagliptin,

Glimepiride & Metformin

Hydrochloride

Tablets

Each film coated tablet contains:

Sitagliptin Phosphate

Monohydrate IP equivalent to

Sitagliptin 50mg

Glimepiride IP 1 mg

Metformin Hydrochloride IP

500mg

1 Tablet

M/s Exemed Pharmaceuticals/ M/s Aristo Pharmaceuticals Pvt. Ltd.

11.52

33

Sitagliptin,

Glimepiride & Metformin

Hydrochloride

Tablets

Each film coated tablet contains:

Sitagliptin Phosphate

Monohydrate IP equivalent to

Sitagliptin 50mg

Glimepiride IP 2 mg

Metformin Hydrochloride IP

500mg

1 Tablet

M/s Exemed Pharmaceuticals/ M/s Primus Remedies Pvt.

Ltd.

13.87

34

Sitagliptin,

Glimepiride & Metformin

Hydrochloride

Tablets

Each film coated tablet contains: Sitagliptin Phosphate

Monohydrate IP equivalent to

Sitagliptin 50mg

Glimepiride IP 2 mg

Metformin Hydrochloride IP

500mg

1 Tablet

M/s Exemed Pharmaceuticals/ M/s Aristo Pharmaceuticals Pvt. Ltd.

14.69

35

Paracetamol,

Phenylephrine HCl,

Chlorpheniramine

Maleate suspension

Each 5 ml contains:

Paracetamol IP 250 mg

Phenylephrine Hydrochloride IP 5 mg Chlorpheniramine Maleate IP 2 mg

1 ml

M/s Res-Sancta Limited / M/s Biological E. Limited

0.71

36

Paracetamol,

Phenylephrine HCl,

Each 5ml (teaspoonful) contains: Paracetamol IP 250 mg

1 ml

M/s Windlas Biotech Limited / M/s Biological E. Limited

0.41

Sl.

No.

Medicines

Strength

Unit

Manufacturer & Marketing Company

Retail

Price

(Rs.)

Chlorpheniramine

Maleate, Ammonium

Chloride, Sodium Citrate & Menthol suspension

Phenylephrine Hydrochloride IP 5 mg Chlorpheniramine Maleate IP

2 mg

Ammonium Chloride IP 120 mg

Sodium Citrate IP 60 mg

Menthol IP 1 mg

37

Diclofenac Injection

Each ml contains:

Diclofenac Sodium IP 75 mg

1ml

M/s Nitin Lifesciences Ltd.

/M/s. Mankind Prime Labs Pvt. Ltd.

31.77

The notification further mentioned;

  • The manufacturer of above-mentioned formulations i.e., ―new drug‖ under paragraph 2(1)(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.
  • The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table.
  • The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.
  • As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
  • The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.
  • In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.
  • Consequent to the fixation of retail price of such formulation as specified in column (2) of the above table with the strength and name of Manufacturer & Marketing Companies specified in the corresponding entries in Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength for that Manufacturer & Marketing Companies as specified in corresponding entries in Column (2), (3) and (5) thereof, if any, issued prior to this notification, stand(s) superseded.
nppadrug price controlessential medicinesretail price fixedanti-diabetic drugscardiac drugsatorvastatinsitagliptinempagliflozinaceclofenacparacetamoltrypsin chymotrypsincholecalciferoldiclofenacpediatric suspensionsprice cappharma pricing
Farhat Nasim
Farhat Nasim

    Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

    Show Full Article
    Next Story

    Editorial

    Penicillin-Binding Protein 3 Inserts in E.coli:A Growing Burden of Underreported Threat

    Penicillin-Binding Protein 3 Inserts in E.coli:A Growing Burden of Underreported Threat

    Management of Hypertension: How Innovative Packaging Can Improve Patient Outcomes?

    Management of Hypertension: How Innovative Packaging Can Improve Patient Outcomes?

    Uncontrolled T2D in India: Valuable Consideration for Dapagliflozin Sitagliptin Combination

    Uncontrolled T2D in India: Valuable Consideration for Dapagliflozin Sitagliptin Combination

    JAPI Releases Dedicated Supplement Addressing Clinical Needs for Adult Vaccination in India

    JAPI Releases Dedicated Supplement Addressing Clinical Needs for Adult Vaccination in India

    Cuticapil Stem Hair Serum as Add-On to Minoxidil Shows Superior Hair Growth in Androgenetic Alopecia : Indian Real World Data

    Cuticapil Stem Hair Serum as Add-On to Minoxidil Shows Superior Hair Growth in Androgenetic Alopecia...

    View All

    Journal Club Today

    Shedding Weight, Losing Muscle: Study Links GLP-1 Drugs to Reduced Muscle Mass

    Shedding Weight, Losing Muscle: Study Links GLP-1 Drugs to Reduced Muscle Mass

    View All

    Health News Today

    Health Bulletin 04/August/ 2025

    Health Bulletin 04/August/ 2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok